Moderna
MRNA
#1217
Rank
NZ$27.28 B
Marketcap
$70.90
Share price
-3.95%
Change (1 day)
-55.91%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -NZ$3.87 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$5.05 Billion. In 2023 the company made an earning of -NZ$7.03 Billion a decrease over its 2022 earnings that were of NZ$17.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$3.87 Billion-44.9%
2023 -NZ$7.03 Billion-140.65%
2022 NZ$17.27 B-27.81%
2021 NZ$23.92 B-1911.15%
2020 -NZ$1.33 Billion44.7%
2019 -NZ$0.92 Billion28.63%
2018 -NZ$0.71 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$74.42 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.93 B-742.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$75.12 Million-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.34 Billion-91.98%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.90 B-646.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-NZ$1.05 Billion-75.09%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$33.08 B-889.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.22 Billion-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA